Deutsch English Français

Contact

EP1560843

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1560843

EP1560843 - NOVEL VARIANTS OF RANKL PROTEIN [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.01.2009 Database last updated on 07.10.2024
Most recent event Tooltip	16.01.2009	Application deemed to be withdrawn	published on 18.02.2009 [2009/08]
Applicant(s)	For all designated states Xencor, Inc. 111 W. Lemon Avenue Monrovia, CA 91016 / US
	[2005/48]
Former [2005/32]	For all designated states Xencor 111 W. Lemon Avenue Monrovia, CA 91016 / US
Inventor(s)	01 / DESJARLAIS, John, R. 2096 Crary Street Pasadena, CA 91104 / US
	02 / HUBERT, Rene, S. 1644 Occidental Boulevard Los Angeles, CA 90026 / US
	03 / YAZAL, Jamal, El 6731 Florence Place Alta Loma, CA 91701 / US
	04 / MARSHALL, Shannon, Alicia 825 Lincoln Way, 106 San Francisco, CA 94122 / US
	[2007/32]
Former [2005/32]	01 / DESJARLAIS, John, R. 2096 Crary Street Pasadena, CA 91104 / US
	02 / HUBERT, Rene, S. 1644 Occidental Boulevard Los Angeles, CA 90026 / US
	03 / YAZAL, Jamal, El 6731 Florence Place Alta Loma, CA 91701 / US
	04 / MARSHALL, Shannon, Alicia 825 Lincoln Way, #106 San Francisco, CA 94122 / US
Representative(s)	Kiddle, Simon John, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
	[N/P]
Former [2005/32]	Kiddle, Simon John, et al Mewburn Ellis LLP York House, 23 Kingsway London WC2B 6HP / GB
Application number, filing date	03713210.7	06.01.2003
	[2005/32]
	WO2003US00393
Priority number, date	US20020345805P	04.01.2002 Original published format: US 345805 P
	US20020373453P	17.04.2002 Original published format: US 373453 P
	US20020374035P	19.04.2002 Original published format: US 374035 P
	[2005/32]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO03059281
	Date:	24.07.2003
	Language:	EN
	[2003/30]
	Type:	A2 Application without search report
	No.:	EP1560843
	Date:	10.08.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.07.2003 takes the place of the publication of the European patent application.
	[2005/32]
Search report(s)	International search report - published on:	US	02.06.2005
	(Supplementary) European search report - dispatched on:	EP	04.08.2006
Classification	IPC:	C07K14/00, C12N5/00, A61K38/00	[2005/32]
	CPC:	C07K14/70575 (EP)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2005/32]
Title	German:	NEUE VARIANTEN VON RANKL-PROTEIN	[2005/32]
	English:	NOVEL VARIANTS OF RANKL PROTEIN	[2005/32]
	French:	NOUVEAUX VARIANTS DE PROTEINES RANKL	[2005/32]
Entry into regional phase	27.07.2004	National basic fee paid
	27.07.2004	Search fee paid
	27.07.2004	Designation fee(s) paid
	27.07.2004	Examination fee paid
Examination procedure	04.08.2003	Request for preliminary examination filed International Preliminary Examining Authority: US
	27.07.2004	Amendment by applicant (claims and/or description)
	27.07.2004	Examination requested [2005/32]
	14.11.2006	Despatch of a communication from the examining division (Time limit: M06)
	31.08.2007	Reply to a communication from the examining division
	01.08.2008	Application deemed to be withdrawn, date of legal effect [2009/08]
	19.09.2008	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2009/08]
Request for further processing for:	31.08.2007	Request for further processing filed
	31.08.2007	Full payment received (date of receipt of payment) Request granted
	14.09.2007	Decision despatched
Fees paid	Renewal fee
	20.01.2005	Renewal fee patent year 03
	27.01.2006	Renewal fee patent year 04
	29.01.2007	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.01.2008	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XY]WO0015807 (M & E BIOTECH A S [DK], et al) [X] 1,3,19-24 * abstract * * page 4, line 5 - page 6, line 5 * * page 29, line 7 - line 19 * * page 29, line 20 - page 36, line 11 * * page 54, line 10 - page 61, line 13 * * claims 17-19,32,53-56 * [Y] 1-3,8,19-26;
		[XY]WO0125277 (MAXYGEN APS [DK]) [X] 1-3,8,19-26 * abstract * * page 12, line 3 - page 13, line 6 * * page 13, line 14 - page 14, line 12 * * page 14, line 15 - line 23 * * page 25, line 1 - page 26, line 14 * * page 26, line 17 - page 27, line 33 * * page 29, line 7 - page 30, line 22 * * claims 21,22 * [Y] 1-3,8,19-26;
		[XY]WO0142298 (KORNBLUTH RICHARD S [US]) [X] 1,3,19-24 * abstract * * page 1, line 8 - line 15 * * page 3, line 11 - page 6, line 9 * * page 29, line 1 * [Y] 1-3,8,19-26;
		[Y]WO0164889 (XENCOR INC [US]) [Y] 1-3,8,19-26 * abstract * * page 6, paragraph 2 * * page 32, paragraphs 1,2 *;
		[DXY] - LACEY D L ET AL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", CELL, CELL PRESS, CAMBRIDGE, NA, US, (19980417), vol. 93, ISSN 0092-8674, pages 165 - 176, XP002125264 [DX] 1 * the whole document * [Y] 1-3,8,19-26 DOI: http://dx.doi.org/10.1016/S0092-8674(00)81569-X
		[XY] - YASUDA H ET AL, "Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis -inhibitory factor and is identical to TRANCE/RANKL", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (19980331), no. 95, ISSN 0027-8424, pages 3597 - 3602, XP002076248 [X] 1 * the whole document * [Y] 1-3,8,19-26 DOI: http://dx.doi.org/10.1073/pnas.95.7.3597
		[T] - STEED P M ET AL, "Inactivation of TNF signaling by rationally designed dominant-negative TNF variants", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, (20030926), vol. 301, no. 5641, ISSN 0036-8075, pages 1895 - 1898, XP002320440 [T] 1-3,8,19-26 * the whole document * DOI: http://dx.doi.org/10.1126/science.1081297
	International search	[X]US6242213

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p